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Abstract
Objective—To examine associations between haplotypes of the serotonin 1B receptor gene and
individual differences in anger and hostility.
Methods—Data were analyzed from a study of 361 university students (47% male). Participants
were genotyped at 5 polymorphisms in the HTR1B gene (rs11568817, rs130058, rs6296, rs6297,
rs13212041), including promoter and 3′UTR polymorphisms with opposite functional effects on
gene expression. Participants reported their emotional states across 30 consecutive days for up to
four years. Haplotype pairs were constructed statistically and assigned to a level of HTR1B
expression based on the presence of the functional polymorphisms.
Results—Six haplotypes accounted for >97% of chromosomes. Three low expression haplotypes
contained the 3′UTR variant (rs13212041 A-allele) that enables a microRNA-mediated reduction
in expression. One intermediate expression haplotype contained the 3′UTR A-allele paired with
the high-activity promoter. Two high expression haplotypes contained the 3′UTR variant
(rs13212041 G-allele) that attenuates microRNA-mediated reduction in expression. Men with low
expression haplotypes reported greater anger and hostility than men with one or two high
expression haplotypes. Diplotype classification accounted for 8.4% of the variance in men’s anger
and hostility, primarily due to the 3′UTR polymorphism (rs13212041), but with some contribution
of the functional promoter combination (rs11568817, rs130058). Associations with anger and
hostility were not found in women.
Conclusions—These findings extend our understanding of the genetic basis of anger and
hostility by showing that newly characterized HTR1B haplotypes, particularly those with
rs13212041, which modulates microRNA-mediated regulation of HTR1B expression, may have
important implications for aggression-related phenotypes among young men.
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Introduction
Individual differences in anger and hostility underlie a variety of adverse or risky health
conditions including elevated cardiovascular risk (Miller et al., 1996), metabolic and
immune dysfunction (Kiecolt-Glaser et al. 2005; Boyle et al., 2007; Goldbacher &
Matthews, 2007; Gouin et al., 2008), intimate partner violence (Norlander & Eckhardt,
2005), maintenance of heavy drinking beyond young adulthood (Costanzo et al. 2007), drug
dependence (De Moja & Spielberger, 1997) and suicide (Baud, 2005; McGirr & Turecki,
2007). Because emotional style is partly heritable (Bouchard, 2004; Cates et al., 1993; Miles
& Carey, 1997), it is important to identify genes that increase risk for this emotional
phenotype.
Animal research on aggression may provide insight into the genetic basis of anger and
hostility. Aggression is closely related to, but distinct from, the constructs of anger and
hostility (Buss & Perry, 1992; Martin, Watson & Wan, 2000). Whereas aggression refers to
observable behaviors of an organism involving approach and attempted harm towards
others, anger and hostility refer to internal emotional and cognitive experiences of an
organism. Feelings of anger and hostility do not always lead to aggression, but they can
precipitate the “hotter,” impulsive form of aggression (Berkowitz, 1983). Aggressive
behavior is also used as a proxy for an angry/hostile phenotype in studies of cardiovascular
risk among higher order primates (e.g., Manuck, Kaplan, & Clarkson, 1983). Taken
together, these links suggest that genes that increase susceptibility to aggression may also
increase susceptibility to angry and hostile emotions.
In the animal literature, studies suggest a role of the serotonin 1B receptor (HTR1B) in
aggressive behavior (for reviews Clark & Neumaier, 2001; Oliver & van Oorshot, 2005;
Popova, 2006). For example, mice lacking serotonin 1B receptors behave more aggressively
than their wild-type littermates (Saudou et al., 1994) and drugs that increase the activity of
the serotonin 1B receptor have anti-aggressive effects on mice placed in paradigms designed
to elicit impulsive aggressive behaviors (Miczek & de Almeida, 2001). Given this evidence,
researchers have sought to identify human HTR1B variants that might influence either the
activity of the serotonin receptor or its level of expression and in turn, the associated
aggressive phenotype.
To date, a select group of HTR1B polymorphisms have been examined in relation to human
aggressive phenotypes. The most frequently studied HTR1B variant, rs6296 [a synonomous
exonic single nucleotide polymorphism (SNP): G861C], has been associated with aggressive
behavior in children (Davidge et al., 2004) and antisocial alcoholism (Lappalainen et al.,
1998; cf. Kranzler et al., 2002). However these allelic associations with aggressive
phenotypes are not consistently found (New et al., 2001). Inconsistent or null associations
have also been reported between rs6296 and other phenotypes related to aggression and
impulsivity including suicidality (with the 861C allele overrepresented among individuals
with personality disorders in New et al., 2001, but not Huang et al., 1999; Nishiguchi et al.,
2001; Rujescu et al., 2003; or Zouk et al., 2007); attention deficit hyperactivity disorder
(found in Hawi et al., 2002; Quist et al., 2003, Smoller et al., 2006; but not Ickowicz et al.,
2007) and substance abuse (Huang et al., 2003). Although the 861C allele was associated
with a 20% lower average number of serotonin 1B receptor binding sites in 96 post-mortem
brain samples (Huang et al., 1999), there is no evidence that the G861C SNP itself is
functional; rather, the high degree of linkage disequilibrium (LD) among previously studied
markers in HTR1B (Cigler et al., 2001; Duan et al., 2003; Proudnikov et al., 2006; Zouk et
al., 2007) suggests that this marker may be in LD with other functional HTR1B
polymorphisms.
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The absence of splicing (HTR1B is encoded by a single exon) or common (>2% frequency)
amino acid coding polymorphisms suggests that any functional variants would exist in
regulatory regions outside the protein coding region. Indeed, two such functional variants
have been described. Duan et al. (2003) provided the first report of functional HTR1B
polymorphisms. Using in vitro reporter gene expression assays, these investigators showed
that two SNPs in the promoter region, −261G paired with the −161 A allele [rs11568817
(T-261G) and rs130058 (A-161T)], increase the binding of transcription factors in the
HTR1B promoter producing a 2.3-fold increase in gene transcription in transfected cells.
They noted that these promoter SNPs were in significant LD with the commonly examined
G861C marker (rs6296). Two groups have examined these promoter SNPs with respect to
human phenotypes. Zouk et al. (2007) investigated the T-261G, A-161T promoter
polymorphisms, plus other previously investigated SNPs (G861C, A1180G, and the lesser
studied C129T), and showed that only the lower expression promoter region −161T allele
predicted higher scores on informant reports of the Buss–Durkee Hostility Inventory in a
sample of suicide completers. The −161T allele was overrepresented among suicide
completers as well (Zouk et al., 2007). Proudnikov et al. (2006) used a hybrid molecular and
statistical haplotyping procedure to examine HTR1B haplotype associations with heroin
dependence. They observed that haplotypes containing a G-allele at rs6297 (A1180G), a
SNP in the proximal region of the HTR1B 3′UTR (Sanders et al., 2001), which has not been
demonstrated to have direct functional effects, were protective for heroin dependence
(Proudnikov et al., 2006). Interestingly, the protective effect of the G-allele at rs6297 was
unrelated to genotype at either the promoter T-261G/A-161T, C129T or G861C alleles,
suggesting that it may be linked to other more distal functional polymorphisms.
Recently, evidence for a second functional regulatory variant was reported by Jensen et al.
(2008) who characterized a SNP occurring in the distal 3′UTR of HTRIB messenger RNA
(rs13212041; A1997G) that disrupts a binding site for the microRNA, miR-96. MicroRNAs
are 20-21 nucleotide ribonucleic acids that regulate gene expression by binding to
complementary sites on messenger RNA triggering mRNA degradation and/or inhibition of
translation (Ambros, 2004; Chendrimada et al., 2007; Baek et al., 2008; Hutvágner &
Zamore, 2002; Kiriakidou et al., 2007; Mathonnet et al., 2007; Selbach et al., 2008; Yekta et
al., 2004; Wakiyama et al., 2007). Jensen et al. used a luciferase reporter gene assay to show
that the rs13212041 polymorphism modulates miR-96 regulation of gene expression. The A-
allele mRNA was repressed by miR-96, while the G-allele attenuated this miR-96 regulatory
function. Importantly, introduction of a compensatory change in mir96 rescued repression of
the G allele, confirming a direct interaction between mir96 and the regulatory element in
HTR1B.
These molecular differences found in Jensen et al. (2008) suggested that A-allele individuals
have reduced HTR1B expression, and greater risk of aggressive behaviors, compared to G-
allele individuals. Indeed, Jensen et al. (2008) found that university students with two copies
of the microRNA-repressed HTR1B A-allele reported a greater history of aggressive
behaviors (e.g., starting fires, damaging property, fighting) than individuals heterozygous or
homozygous for the G-allele. Genotype differences were not found in non-aggressive anti-
social behaviors (e.g., lying). As yet, it is not known whether this 3′UTR microRNA
targeting polymorphism (rs13212041) is in LD with other known polymorphisms (i.e.,
rs11568817, rs130058, rs6296, rs6297) and whether these polymorphisms act synergistically
or, potentially, antagonistically to influence risk for other aggression-related emotional
phenotypes such as anger and hostility. For example, it is not known whether the 3′UTR
(rs13212041) and 5′-promoter functional alleles (rs11568817, rs130058) are inherited
separately or together, and if together, what those inherited combinations are. In addition,
linkage with the 3′UTR could explain previously found effects. For example, co-inheritance
of the 1180G allele of rs6297 and the 3′UTR G-allele of rs13212041 could explain why
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rs6297 has been linked to other impulsive disorders (Proudnikov et al., 2006) in the absence
of both known functional effects of rs6297 and associations of it with currently known
functional SNPs.
In this report, we examined the recently characterized 3′UTR functional SNP (rs13212041;
A1997G; Jensen et al., 2008), the two functional promoter region SNPs (rs11568817,
rs130058; Duan et al., 2003), and two other commonly studied SNPs, rs6296 and rs6297,
and their associations with individual differences in anger and hostility. Because these
markers span a relatively short genetic interval of 2,258 base pairs, they are expected to
show considerable LD. Thus, we also examined the pattern of LD among markers and
identified naturally occurring haplotypes. With this approach, we could determine whether
the 5′-promoter and 3′UTR functional alleles are inherited together or separately, as well as
their linkage with the G861C and A1180G alleles, which others have examined in relation to
human phenotypes. We then classified the haplotypes expected to have lower versus higher
levels of gene expression based on prior molecular research showing functional effects of
rs11568817, rs130058, and rs13212041. Finally, we tested whether individuals with the
predicted lower expression HTR1B diplotypes scored higher on their reports of anger and
hostility than those with predicted higher HTR1B expression diplotypes.
Self-reports of anger and hostility were measured using real-time data capture techniques
(Stone, Shiffman, Atienza & Nebeling, 2007). Participants completed a daily report of
current feelings of anger and hostility for 30 consecutive days, for up to four years. By
aggregating multiple emotion state reports over time, we could obtain a highly reliable and
stable assessment of anger and hostility over a four-year period of early-adulthood, roughly
from ages 18 to 21. This approach also reduced error in the emotion measurement, thereby
increasing the statistical power to detect genotype-phenotype associations.
The present study uses the same human sample as in Jensen et al. (2008) but it extends the
prior report in three critical ways. First, the present investigation helps to integrate prior
literature by genotyping the four most commonly occurring polymorphisms in addition to
the one in the 3′UTR and testing their LD. Second, the present investigation uses a
haplotype approach to examine the natural pattern of inheritance for these five markers. A
haplotype approach provides a biological point of reference for the inheritance of the
potentially synergistic or opposing effects of these polymorphisms. Third, the present
investigation uses a more extensive phenotype measure. Whereas Jensen et al. (2008)
analyzed a single checklist of past aggressive behaviors, the present investigation analyzed
real-time reports of anger and hostility measured in a robust and ecologically valid fashion
over four years. Moreover, the content of the questions—asking about common everyday
emotions (anger and hostility) rather than relatively uncommon aggressive events (setting
fires; starting fights; as in Jensen et al.)— may further increase power to detect genetic
associations via more refined differentiation among subjects.
Method
Participants
The sample consisted of 361 university students (168 men; 193 women) from a mid-sized
US state university. It was derived from a sample of 575 participants in a four-year
longitudinal study who provided DNA samples (N = 416). To avoid population
stratification, we limited the analysis sample to individuals of non-Hispanic Caucasian
ancestry. This sample included individuals analyzed elsewhere for unrelated hypotheses
(Armeli et al., 2008; Covault et al., 2007; Gacek et al., 2008; Gunthert et al., 2007). The
average age of sample participants at the start of this four-year study was 18.7 +/ 0.9 yrs
with 61% percent freshmen, 32% sophomores, and 7% upper classmen. All participants
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gave written informed consent under guidelines approved by the Institutional Review
Boards at the University of Connecticut (Storrs) and the University of Connecticut Health
Center (Farmington).
Measures and Procedure
In each year, participants completed an initial assessment battery one month following the
start of either the fall (59% of participants) or spring (41% of participants) semester by
accessing a secure website. This on-line assessment included demographic variables and the
history of aggression questionnaire reported on previously (Jensen et al., 2008).
Approximately two weeks after the initial assessment, participants logged on to a secure
website to complete a 5-minute survey between 2:30 and 7:00 p.m. daily for 30 days. The
daily survey contained questions about a range of behaviors and experiences, including
current emotional states. Using a 5-point scale from 1 (very slightly/not at all) to 5
(extremely), participants rated how “angry” and “hostile” they felt right now, and these
responses were averaged within each daily survey for a measure of hostility (α = .76).
Participants also rated how “sad” and “dejected” they felt, averaged for sadness (α = .75);
“jittery” and “nervous” for anxiety (α = .72); and “cheerful” and “happy” for happiness (α
= .88). Participants repeated this same 30-day survey procedure every fall or spring for up to
four years.
We initiated DNA collection in year two of the study. At that time, the 535 participants who
were thought to be still living in the area were invited to participate in a genetic sub-study,
with eligibility to continue in the larger study not contingent on providing a sample for
DNA. Of those invited, 416 (77.8 %) consented to provide genetic data, 69 (12.9 %)
declined, 34 (6.4%) did not respond and 16 (3.0%) had moved out of the area. After giving
informed consent, participants were asked to “swish” Scope™ mouthwash (Procter and
Gamble, Cincinnati, Ohio) for 20-30 seconds, and then spit the mouthwash into a collection
tube. The 416 participants who consented to provide DNA samples did not differ from the
other 119 participants on any of the primary outcome variables, although consenters were
more likely to be female (χ2 = 7.74, p < .01), younger (18.7 vs. 19.0 years, p < .05), and to
participate in the study longer (3.5 vs. 2.3 years, p < .001).
Genotyping
DNA was extracted from mouthwash-stabilized samples using a commercial DNA isolation
protocol (PureGene, Gentra Systems, Minneapolis, MN). The five HTR1B polymorphisms
were genotyped using PCR-based TaqMan® allelic discrimination assays. A 10μl PCR
reaction was prepared in 1x ABI TaqMan Universal master mix (Applied Biosystems Inc.,
Foster City, CA) containing 100nM of each Fam and Vic-labeled allele specific TaqMan®
MGB probes, and 600nM of each forward and reverse primer (Table I). For the promoter
SNPs, rs115688177 and rs130058, primers and probes were as described by Proudnikov et
al. (2006). MGB-probes and primers for the remaining 3 SNPs were designed using Primer
Express v3.0 software (Applied Biosystems Inc.). The polymerase chain reaction was
performed with the following cycling parameters: 95°C for 10 minutes, followed by 40
cycles of 95°C for 15 seconds and 60°C for 60 seconds. End point FAM and VIC
fluorescence levels were captured using an ABI 7500 Sequence Detection System (Applied
Biosystems Inc.) and genotype calls were made based on the level of fluorescence signal.
The genotyping assay was repeated for 13% of samples with no discrepancies in genotype
calls. Finally, we carried out molecular 2-SNP analysis of the T-261G and A-161T
polymorphisms using the A-161T TaqMan probe and downstream primer paired with
T-261G allele-specific forward primers (CCAGCTCTTAGCAACCCAGTT or
CCAGCTCTTAGCAACCCAGTG) as described by Proudnikov et al. (2006) with genotype
calls made by examining change in fluorescence as a function of cycle number for each
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sample. The resulting molecular 2-SNP allele calls were in agreement with haplotypes
statistically determined using Phase 2.1. The 2-SNP haplotype – 261T/-161T was not
observed. (Table I Here)
Data analysis
The survey data were screened prior to analyses to exclude participants who provided fewer
than the minimum of 15 of 30 daily surveys for a given year following our standard protocol
(Covault et al., 2007). Five of the 361 participants failed to meet this minimum standard in
any of the years and were eliminated from all survey analyses. We also limited our analyses
to years in which participants were undergraduate students to ensure that data were from a
similar population. This screening did not compromise the sample, as the majority of
participants were undergraduate students throughout the study. Thus, we retained data across
an average of 3.1 years (+/− 0.9), reflecting an average of 79 reports per person (+/−27)
(range 16 – 120 reports). The Hierarchical Linear Modeling statistical software program
(HLM; 6.04 (Raudenbush, Bryk, & Congdon, 2007) was used to examine associations
between the survey data and the genetic information. This approach took into account the
unbalanced (e.g., varying number of daily and yearly reports) and nested nature of the data.
We ran hierarchical linear models to test (i) whether average hostility scores differed across
each genotype group; (ii) whether hostility scores differed across the common haplotype
configurations; and (iii) whether hostility scores differed across diplotypes. Men and women
were analyzed separately to provide separate effect size estimates. More detailed
descriptions of the hierarchical linear models are found in Supplementary Materials.
Linkage disequilibrium (LD) plots, haplotype blocks, and haplotype frequencies for the
sample of Caucasian students were generated using the software program Haploview v3.2.2
(Barrett et al., 2005). Best-estimate haplotype pairs for each individual subject were
generated using Phase v2.1 software, which incorporates a Bayesian statistical method for
reconstructing estimated haplotypes from population data (Stephens et al., 2001; Stephens &
Donnelly, 2003).
Results
Genotype frequencies for the 361 Caucasian participants are presented in Table II. All
frequencies were in Hardy-Weinberg Equilibrium. Allele frequencies for the 5 SNPs were
consistent with prior reports in the literature.
Genotype Results
Genotype differences in hostility for men and women are shown in Table III. Only men
showed significant differences in hostility as a function of genotypes. Of the five genotypes
tested, the 3′UTR variant (rs13212041) showed the largest differences in hostility scores
among the men, with the AA vs. G carrier difference accounting for 7.1% of the variance in
hostility scores. Rs6297 also showed significant differences, with the AA vs. G carrier
difference accounting for 4% of the variance. Analysis of rs130058 and rs6296 both yielded
non-significant trends, and each accounted for approximately 2% of the variance in hostility
ratings. Rs115688177 was unrelated to hostility. Genotypes were also related to sadness and
anxiety for men only, although effect sizes were generally smaller for these measures than
for hostility (see Supplementary Materials, Table S-1). For example, the 3′UTR variant
(rs13212041) accounted for 4.0% and 4.9% of the variance in anxiety and sadness,
compared to 7.1% of the variance in hostility. Genotypes were unrelated to happiness either
for men or women.
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Haplotype Results
The 5 markers examined were in a single haplotype block with D”values of 0.87 to 1.0 (see
Figure 1). Six haplotypes comprised >97% of chromosomes (See Table IV). The frequency
of haplotypes as estimated for the entire sample by Haploview was in close agreement with
the frequency based on individual subject best-estimate haplotype pairs generated using the
Phase software application. The observed haplotype frequencies were comparable with
frequencies reported using a subset of these markers (Duan et al., 2003; Proudnikov et al.,
2006).
For the 6 common haplotypes, we classified three as having lower HTR1B gene expression
(GTGAA, TACAA, and TAGAA) and three haplotypes as having higher HTR1B gene
expression (GAGAA, TAGGG, and TAGAG). We based this classification on in vitro
functional assays by Duan et al. (2003) who showed that the GA pairing at T-261G and
A-161T had a 2.3-fold higher transcriptional activity and Jensen et al. (2008) who showed
that the rs13212041 G-allele attenuated microRNA-mediated down regulation of gene
expression relative to the A-allele. This classification combined the putative transcriptional
and microRNA-mediated mRNA translation/stability effects contributed by the two separate
functional polymorphisms.
With these haplotypes (see Table IV), it is interesting to note that the 861C allele, which had
previously been reported to be associated with reduced HTR1B binding sites in post-mortem
brain (Huang et al., 1999), was observed only in the lower expression TACAA haplotype
containing the rs13212041 A-allele. Similarly, the −161T allele, which had previously been
associated with increased hostility (Zouk et al., 2007), was observed only in the lower
expression GTGAA haplotype containing the rs13212041 A-allele. Lastly, the rs6297
1180G allele, which had previously been shown to have a protective effect for heroin
dependence (Proudnikov et al. 2006), was observed only in the higher expression TAGGG
haplotype containing the rs13212041 G-allele.
We then examined the relation between the six common haplotypes and the hostility ratings
from the daily survey data (see Table V). As predicted, but for men only, haplotypes
expected to have lower HTR1B mRNA expression (TACAA, GTGAA, TAGAA) were
associated with higher levels of self-reported hostility, whereas haplotypes expected to yield
high HTR1B levels (TAGAG, TAGGG) were associated with lower levels of hostility. The
GAGAA haplotype containing the high-activity GA promoter with the low-activity 3′UTR
A-allele was associated with intermediate levels of hostility. It is notable that we did not
observe the haplotype GAxxG containing the more inducible promoter (GA at T–261G/A–
161T) paired with the microRNA binding site disrupted by the G-allele. Instead, we
observed only the haplotype GAGAA, containing the more inducible promoter paired with
the active microRNA binding site (A-allele). This pattern of inheritance coupled with the
intermediate score for the hostile mood phenotype measure suggests that the functional
increase in activity of the GA promoter may be ameliorated by microRNA-mediated down
regulation of gene expression by the rs13212041 A-allele. As such, the haplotype GAGAA
was classified as having intermediate HTR1B expression for consideration of diplotype
associations with phenotype.
Diplotype Results
We computed a diplotype score for each participant based on the predicted HTR1B activity
value of both haplotypes. Each haplotype was assigned a value: “0” for lower-activity
haplotypes (TACAA, GTGAA and TAGAA), “0.5′for the intermediate-activity haplotype
(GAGAA), and “1′for higher-activity haplotypes (TAGAG and TAGGG). The two
haplotype values were added, yielding five HTR1B diplotype activity levels (0, 0.5, 1, 1.5 or
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2). Frequencies were as follows: 0 = 141 (40%); 0.5 = 81 (23%), 1 = 99 (28%); 1.5 = 21
(6%); 2 = 13 (3%). Six participants could not be assigned a diplotype due to missing
haplotype information for one chromosome. The majority (92 of 99) of those with a
diplotype score of 1 had one high and one low-activity haplotype; the remainder (7 of 99)
had two intermediate activity GAGAA haplotypes containing both the −261G/A-161
promoter alleles and 3′UTR miR-96 binding site A-allele. Because of the low frequency of
participants with two intermediate activity haplotypes (2 men; 5 women), we grouped them
with the other 92 participants with a diplotype score of 1 in subsequent statistical analyses.
Diplotype frequencies did not vary by gender, χ2 = .70, p = .951 [men: 0 = 67 (40%); 0.5 =
37 (22%), 1 = 46 (28%), 1.5 = 11 (7%), 2 = 5 (3%), plus two unassigned; women 0 = 74
(39%); 0.5 = 44 (23%); 1 = 53 (28%), 1.5 = 10 (5%); 2 = 8 (4%), plus four unassigned].
Mean hostility and other emotion scores as a function of diplotypes are shown in Table VI.
The pattern of means showed that men (top rows) with no high-activity haplotypes (0s)
reported the highest levels of hostility, compared to men with one or more higher-activity
haplotypes (1s, 1.5s, 2s). Men with one intermediate activity haplotype containing the
GAxxA sequence (0.5) reported intermediate levels of hostility. The similar hostility scores
among men with one or more high activity haplotypes (1s, 1.5s, 2s), suggested a dominant
effect of higher-activity haplotypes containing the G-allele of rs13212041. 1 In fact, the
presence of one or more higher-activity haplotypes (vs. one intermediate vs. none)
accounted for 8.4% of the variance in hostility corresponding to a Cohen”s d of 0.62, a
medium effect size (Cohen, 1988). This effect size is stronger, although not substantively so,
than the effect size found when testing rs13212041 alone (7.1%; d = .57).
Men with no higher expression chromosomes also reported significantly more anxiety and
sadness (see Table IV); however effect sizes were smaller than those observed for hostility
(5.8% and 6.3% of the variance, ds = .50 and .52, respectively). Furthermore, when
controlling for hostility2, the diplotype associations were substantially attenuated for anxiety
and sadness (Anxiety % var = 4.0, d = .42; b(SE) = −.149(.060), p = .015; Sadness % var =
2.0, d = .32; b(SE) = −.072(.039), p = .067). By contrast, the diplotype association with
hostility was minimally attenuated when controlling for anxiety (% var 7.9, d = .61; b(SE) =
−.184 (.056), p = .002), sadness (% var 7.6, d = .60; b(SE) = −.121(.040), p = .003), or both
sadness and anxiety together (% var 7.1%, d = .57; b(SE) = −.106(.037), p = .005). These
patterns suggest that diplotype was associated most strongly with hostility, which partially
accounted for the associations with anxiety and sadness, although not completely. Diplotype
associations were not observed in reports of happiness for men.
Women showed no significant differences in daily self-reported hostility, sadness or
happiness as a function of diplotype (see Table VI). Women with higher expression
chromosomes did have higher anxiety than their peers. This finding was unexpected and
warrants future replication.
Additional Moderators
We conducted exploratory analyses to examine whether diplotype effects varied with age
(See Supplementary Analyses). Indeed, diplotype differences in hostility were strongest
1This effect was the same when excluding the two men with two intermediate activity haplotypes and retaining only the men with one
high/one low activity diplotype (all with diplotype scores of 1). Interestingly, the two men with two intermediate activity haplotypes
evidenced greater hostility (M(SD) = 1.52(.48) than the other men with one high/one low activity haplotype (M(SD) = 1.24(.27). This
pattern is consistent with the observation that the Gallele in the 3′UTR binding site, present in those with one high/one low activity
haplotype, exerts a dominant effect on ameliorating hostility.
2Following guidelines by Raudenbush & Bryk (2002, pp. 33), hostility was entered as a grand-mean centered level-1 predictor.
Similar to ANCOVA, this approach yields an adjusted intercept reflecting the expected value of anxiety (or sadness) for an individual
at the grand mean of hostility.
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among 18-year-old men (b(SE) = −.314(.077), p < .001), followed by 19-year-old men
(b(SE) = −.272(.069), p < .001), 20-year-old men (b (SE) = −.230 (.069), p = .001) and 21-
year-old men (b(SE) = −.188(.075), p = .014). This pattern suggests that HTR1B genetic
associations with hostility are stronger in younger men.
Discussion
These findings extend our understanding of the genetic basis of anger and hostility and
suggest that common functional haplotypes in the serotonin 1B receptor gene are risk factors
in the experience of hostile emotional states. Male university students with two low-activity
HTR1B chromosomes reported feeling significantly more anger and hostility in their daily
lives than their peers with at least one high-activity HTR1B chromosome. Male students
with one low and one intermediate HTR1B activity chromosome reported intermediate levels
of hostility. This three-group diplotype configuration accounted for 8.4% of the variance in
men”s reports of hostility (Cohen”s d = .62)—a medium effect size that is substantially
higher than many other single-gene association studies of a behavioral phenotype, which
more typically account for 2– 4% of variance in phenotype (e.g., Covault et al., 2007; Lesch
et al., 1996).
Much of the variance accounted for by the diplotype was attributable to the microRNA
binding site polymorphism (rs13212041), which explained 7.1% of the variance in men”s
reports of hostility (d = .57). Indeed, the G-allele of rs13212041 appeared to drive the
dominant protective effect of high-activity diplotypes on men”s hostility. This pattern
suggests that the microRNA binding site polymorphism has greater behavioral effects than
the promoter variant. Yet, this microRNA site polymorphism alone did not completely
account for HTR1B associated phenotypic differences. The addition of haplotype
information, namely the inclusion of the GA-promoter to distinguish intermediate
diplotypes, explained an additional 1.3% of the variance. Consequently, we believe that the
GA-promoter information is useful to include, particularly given the frequency of the
intermediate haplotype (GAGAA, which represented 16% of haplotypes).
The results of our haplotype examination inform prior studies examining other HTR1B
markers linked to the two functional alleles examined here. The rs6296 861C allele
previously associated with 20% fewer HTR1B binding sites (Huang et al., 1999) was only
observed in the haplotype containing a low activity promoter together with the microRNA
repressed rs13212041 A-allele (TACAA). In a study of heroin addiction (Proudnikov et al.,
2006), the protective HTR1B rs6297 allele(1180G) was observed only in association with
the inactive microRNA binding site 1997G allele (TAGGG). Lastly, the –161T allele at
rs130058 reported to be associated with higher scores on the Buss–Durkee Hostility
Inventory and overrepresented among suicide completers (Zouk et al., 2007) was only
carried on a haplotype containing the microRNA-sensitive rs13212041 A-allele (GTGAA).
In each case, the association of other SNPs with increased psychopathology or decreased
HTR1B protein expression could be explained by the presence of the microRNA active A-
allele (leading to less HTR1B activity), while the protective effect of the 1180G allele could
be explained by the presence of the microRNA inactive G-allele (leading to more HTR1B
activity).
We also found an association between HTR1B diplotype and both anxiety and sadness.
Although not predicted, this association is consistent with several lines of research. First,
both anxiety and depression have been consistently linked to hostility (Kennedy, Morris,
Pedley, & Schwab, 2001; Swan, Carmelli & Roseman, 1989; Suls & Bunde, 2005). Second,
the pharmacological treatment literature reveals that anxiolytics and serotonergic
antidepressants are effective not only in the treatment of anxiety and depression,
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respectively, but also in the treatment of aggressive behaviors (reviewed by Lavine, 1997).
The psychological treatment literature also demonstrates that interventions directed toward
anger reduction also reduce anxiety and depression (Deffenbacher, Dahlen, Lynch, Morris &
Gowensmith, 2000). That the associations to anxiety and depression emerged among men is
consistent with the notion that men are vulnerable to masked or hidden depression in the
form of aggressive behavior (Fischer & Good, 1997; see also Hankin & Abramson, 2001)
and that gender norms lead some depressed men to exhibit externalizing symptoms (but see
Addis, 2008 for a critique).
The present findings have several implications. They highlight the importance of a
comprehensive molecular genetic approach linking functional variants in candidate genes to
complex phenotypes. In this way, our findings build on previous research by Duan et al.
(2003) and Jensen et al. (2008) suggesting that there are multiple functional HTR1B
polymorphisms and several common haplotypes in the population. Our results also
demonstrate an important role for microRNA directed repression of HTR1B in the
modulation of hostile emotions. The A-allele at rs13212041 appears to predispose
individuals to a more hostile emotional style via microRNA-directed repression of the
HTR1B mRNA, consistent with our previous study (Jensen et al., 2008). By contrast, the G-
allele appears to predispose young men to a less hostile emotional style by the blocking
microRNA-directed repression. Whereas two A-alleles are necessary for increased hostility
risk, one G-allele is enough to reduce such risk. We also found that there is linkage between
the GA promoter of Duan et al. and the microRNA polymorphism of Jensen et al.
Interestingly, the −261G/A-161 promoter variant does not appear to act together with the
microRNA G-allele to create a “super high expressing” chromosome. Instead, the GA
promoter occurred only with the low expression microRNA A-allele (GAGAA). These
findings suggest that when inherited together, the high-activity GA promoter and low-
activity A-allele temper one another, resulting in an intermediate HTR1B behavioral
phenotype. Additional research is necessary to validate these patterns and demonstrate their
presence in other populations. Findings may also implicate these functional haplotypes in
other health and psychological conditions linked to hostility. Hostility has been
independently related to increased cardiovascular reactivity (e.g., Räikkönen et al., 1999),
impaired immune function (e.g., Kiecolt-Glaser et al., 2005), substance dependence (e.g.,
Costanzo et al., 2007; De Moja & Spielberger, 1997) and suicide (e.g., Baud, 2005; McGirr
& Turecki, 2007). Genetic research in these areas may profit from investigating the 3”UTR
microRNA binding site variant (rs13212041) and associated HTR1B haplotypes.
It is interesting that in our four-year longitudinal study, the strongest genetic differences for
males occurred at age 18, and decreased somewhat thereafter. This pattern suggests the
existence of developmental effects; however, given the small age range in this sample (18 –
21 years), we could examine these age effects only in an exploratory fashion. Future
research needs to examine age effects in a sample with a larger age range (e.g., 18 – 50+). If
age-related effects were found, it might suggest that phenotypic manifestation of these
genetic variants depend on developmental factors, i.e. prefrontal cortical function, hormone
levels, etc. Future research combining genotyping with fMRI, hormone assays, and/or
additional psychosocial questionnaires would help to disambiguate key moderators.
Moreover, examination of the effects of HTR1B haplotype differences on hostility in
individuals outside college-age individuals—for example, in adolescent boys or older adult
men—could help determine the broader implications of these genetic variants. If differences
were observed among adolescent boys, the HTR1B haplotypes could be considered a risk
factor for teen aggression and its correlates (fights, arrests, drug and alcohol use, etc.). If
genetic differences persisted among adult men, HTR1B haplotypes could be confirmed as a
potential cardiovascular risk factor (e.g., Type 1 personality: Miller et al., 1996).
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No genotype differences were observed among women. This finding could be interpreted
biologically, for example, that only men with low-expression haplotypes are especially
prone to aggression-related emotional states due to hormonal or other Y chromosome-linked
neural circuitry differences. However, this interpretation is tempered by the fact that these
same women showed significant an association of the rs13212041 SNP with self-reported
earlier lifetime behaviors (Jensen et al., 2008). A-allele homozygous women at rs13212041
reported a history of more aggression-like behaviors (starting fires, damaging property, and
fighting) than G-allele carrier women. Therefore, a more parsimonious explanation is that
women with low HTR1B expressing chromosomes may manifest the aggressive phenotype,
but they do so earlier in their development. Research has shown that genetic influences on
aggressive behaviors are stronger earlier in development among female than male children
(e.g., for antisocial behaviors: Jacobson et al., 2002). Indeed our own data indicate that the
genotype difference in hostility among males was highest at age 18. If so, then a
retrospective history checklist covering the period including childhood to late adolescence
could reveal further genetic associations of these HTR1B haplotypes with hostile emotional
states among women. Yet, other work has shown that genetic influences on aggression tend
to increase for both boys and girls from childhood to young adulthood (Jacobson et al.,
2002; Miles & Carey, 1997). Additional research is needed to replicate and determine the
mechanism for this gender-specific effect.
There are several methodological strengths in the present study. First, design considerations
reduced the likelihood of Type 1 error (moderate sample size; robust measurement of
emotional outcomes; demonstrated consistency in findings longitudinally). Second, our
choice of HTR1B as a candidate gene was based on studies in animals and humans that
implicate this gene in aggressive behavior. Third, three of the five SNPs we examined have
previously been shown to modulate two key steps in gene expression: transcription and
mRNA translation (Duan et al., 2003; Jensen et al., 2008). Nonetheless, because of the risk
for Type 1 error in genetic association studies, we strongly advocate efforts to replicate these
findings.
There are also limitations to this study that should be considered. As a genetic association
study, our study was correlational in design. Although Duan et al. (2003) and Jensen et al.
(2008) established functional effects of three of the SNPs studied, these polymorphisms
could also be in LD with other yet to be identified genetic variants that are functional. Our
use of haplotype analysis partially addressed this issue by examining linkage among
previously identified and commonly studied SNPs. Also, we assumed a static effect of these
functional variants on HTR1B gene expression, yet it is possible that these polymorphic
regulatory elements have a dynamic effect on the phenotype. For instance, the emotional
effects of the HTR1B 3′UTR A/G polymorphism should depend on the presence and activity
level of the complementary microRNA (miR-96), yet microRNAs are not continuously
active—their amount and activity are regulated by a variety factors still being discovered
(Davis et al., 2008, Newman et al., 2008; Viswanathan et al., 2008; Zhou et al., 2008). As a
result, it is possible that miR-96 does not exert its effect in all individuals with the
rs132120411041 A/A genotype because of other factors that regulate the production and
activation of miR-96. Future studies may profit from identifying factors that control the
expression and activity of miR-96 and ascertain their potential interaction with genotype to
predict hostility. Similarly, the functional effects of the GA promoter haplotype may be
conditional on the presence of Ap1-mediated transcription inducers and its effect may be
most evident under specific developmental, environmental or life experience conditions.
Because our analysis was limited to non-Hispanic Caucasians, it is important to examine
these associations in more diverse samples.
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Finally, future studies of the association of this SNP with psychological phenotypes might
also include standard trait measures that target anger and hostility. However, we anticipate
that the effect sizes may be attenuated with standard trait measures as compared with real-
time data capture techniques. Although we have assessed emotional states repeatedly over
four years, our aggregation of these repeated state assessments essentially created a trait
indicator of anger/hostility. We believe that this aggregated indicator of emotional states
may be more reliable and less vulnerable to recall error and bias than traditional, once-
administered, questionnaire-based trait measures. At the same time, our two-item indicator
lacked the breadth of standard trait measures.
Conclusion
Our study broadens the genetic bases of emotionality and suggests a link between common
haplotypes in the serotonin 1B receptor gene and angry and hostile emotions in daily life
among young men. Phenotypes were best explained by haplotypes that varied in the
microRNA binding polymorphism (rs13212041) and, to a lesser extent, the promoter
variants (rs11568817 and rs130058). These findings add to a growing literature showing that
polymorphisms that influence gene expression related to the serotonin 1B receptor gene play
an important role in phenotypic variation—particularly that which is part of a broad
aggression-related cluster, which includes anger and hostile emotions. Additional research is
needed on the correlates of these haplotypes and the mechanisms by which they exert effects
on phenotype, particularly the brain-based processing differences and affective mechanisms
that may underlie gene-based emotional differences, e.g., using neuroimaging (e.g., Canli et
al., 2006; Hariri et al., 2002). Finally, the apparent gender-specific and potentially
developmental manifestations of the association should be examined further and taken into
account in subsequent studies of the SNPs examined in this study. Use of real-time data
capture techniques may help to increase effect sizes in future genetic association studies.
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Figure 1.
/I> Haploview generated LD plot illustration for Caucasian participants. Values shown
represent 100 × ∣D”∣, empty boxes represent a value of 100 (i.e. D”=1). The location of 5
SNPs across the 2,258 bp HTR1B gene are schematically noted at the top beginning with the
T–261G promoter region SNP rs115688177 at the far left and the 3′UTR microRNA site
SNP rs13212041 at mRNA position 1,997 at the far right.
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Table I
HTR1B SNPs Examined in this University Student Cohort
NCBI SNP
(dbSNP build
126)
Location
relative to
HTR1B1
PCR amplicon primers TaqMan MGB probes(SNP position in bold)
rs115688177 Promoter AGCGGAGCAGGGCTCG Vic- CCCAGGGCTAAGAC
T-261G TTCCTCAATTATTCCTCCGCC 6FAM- CCCAGGTCTAAGACC
rs13058 Promoter GCGGCTTAGCTAGGCGCT Vic- CACCCTTGACCTCTA
A-161T CGCAGGTTTGTCCCCAGTT 6FAM- CACCCATGACCTCT
rs6296 Exon 1 CGTCCTCGGTCACCTCTATTAACT Vic- CTCCTGTGTATGTGAAC
G861C GTCGGAGACTCGCACTTTGACT 6FAM- TCTCCTGTGTATGTCAAC
rs6297 Exon 1 AAACAAGCATTCCATAAACTGATACG Vic- ACTTGCCATTTGC
A1180G GGTCCCCAAAGGTCGCTTAG 6FAM- TGACTTGCCGTTTGCAGT
rs13212041 3′UTR AAAGTGACAGGTACATGAAATTAAGAGAA Vic- TGCAGACTTTGGC
A1997G CACAACTCTAACAAACAAACCATTATGTG 6FAM- TGCAGACTTCGGC
1
Nucleotide position relative to HTR1B ATG using the March 2006 version of the human genome chromosome 6 annotation
(www.genome.ucsc.edu).
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